<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: recurrent disease</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Post-treatment pain in head and neck cancer patients linked to recurrence, lower survival rate</title>
   	 <description>Patients with head and neck cancer who experience a higher level of post-treatment pain appear to have a lower survival rate than those who experience little or no post-treatment pain, according to a report in the August issue of Archives of Otolaryngology-Head &amp; Neck Surgery.</description>
     <link>http://www.physorg.com/news169752374.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 17 Aug 2009 19:20:01 EST</pubDate>
	 <guid isPermaLink="false">news169752374</guid>
</item>
<item>
     <title>Biomarker predicts disease recurrence in colorectal cancer</title>
   	 <description>Findings published in the Journal of the American Medical Association by researchers at Thomas Jefferson University show that the presence of a biomarker in regional lymph nodes is an independent predictor of disease recurrence in patients with colorectal cancer.</description>
     <link>http://www.physorg.com/news154116671.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 17 Feb 2009 18:12:03 EST</pubDate>
	 <guid isPermaLink="false">news154116671</guid>
</item>
<item>
     <title>Plasma DNA level is a reliable marker of recurrent esophageal cancer, study finds</title>
   	 <description>New research published in the July issue of the Journal of the American College of Surgeons shows elevated plasma DNA is a reliable marker of recurrent esophageal cancer. The study also suggests that plasma DNA levels rise before clinical evidence of cancer recurrence in the majority of patients.</description>
     <link>http://www.physorg.com/news136195871.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 25 Jul 2008 09:11:11 EST</pubDate>
	 <guid isPermaLink="false">news136195871</guid>
</item>


</channel>
</rss>

